Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Devices

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

Revenue projections:

Revenue projections for STE
Revenue projections for STE

Revenues for STE are forecasted to decline from last year's levels, prompting caution among investors. When revenues fall, it can have a significant negative impact on the company's bottom line, reducing profitability and making the stock less attractive to risk-averse investors.

Financial Ratios:

currentRatio 2.479000
forwardPE 20.012177
debtToEquity 28.651000
earningsGrowth 0.121000
revenueGrowth 0.092000
grossMargins 0.443220
operatingMargins 0.184940
trailingEps 7.180000
forwardEps 11.078750

STE's current ratio is 2.479, signaling that the company has sufficient cash reserves and current assets to cover its short-term debt obligations. This suggests financial stability, as STE should not face any issues meeting its short-term liabilities with available resources.
STERIS plc's Forward PE is in an attractive range, meaning its stock price aligns well with earnings and isn't inflated. This creates room for growth, making it a solid investment opportunity for those looking to benefit from potential price appreciation.
STE's low Debt-to-Equity ratio shows that the company avoids excessive reliance on debt, reducing financial risk. This suggests a more secure financial position with less vulnerability to debt-related risks, making STE a stable and conservative investment.
STERIS plc's forward EPS surpasses its trailing EPS, indicating that the company is expected to be more profitable in the current financial year. This reflects growing confidence in STERIS plc's earnings potential, suggesting stronger financial performance compared to the previous year.

Price projections:

Price projections for STE
Price projections for STE

STE's present price, in relation to projections, does not offer clear risks or opportunities. This stable scenario suggests a period of consolidation, where investors might prefer to hold off on significant changes in strategy.

Insider Transactions:

Insider Transactions for STE
Insider Transactions for STE


STE had 10 sell transactions, while the market price was at 249.27000122070314 per share.No sell transactions were completed during the period under review.An increase in buying activity relative to selling at STERIS plc's current price might suggest a favorable sentiment among investors. This trend could be interpreted as a sign that the stock has a positive outlook in the near term.

Recommendation changes over time:

Recommendations trend for STE
Recommendations trend for STE


Analysts have been favoring STE with a buy bias recently, signaling a promising investment opportunity. This optimistic outlook may attract more investors, positioning STE as a desirable option for those seeking to invest their money in a stable, profitable company with strong growth potential.